Gracey Craig 4/A

4/A · Omada Health, Inc. · Filed Jul 8, 2026

AI-generated summary of this filing

Updated Jul 9, 2026

Omada Health (OMDA) CAO Gracey Craig Exercises Options, Sells Shares

What Happened

Gracey Craig, Chief Accounting Officer of Omada Health (OMDA), exercised a total of 4,167 option-derived shares and immediately sold those shares in same-day transactions.
On 2026-06-26 she exercised 2,084 shares at $6.57 each (cost $13,692) and sold them at $20.00 each for $41,680. On 2026-06-29 she exercised 2,083 shares at $6.57 each (cost $13,685) and sold them at $21.00 each for $43,743. Total exercised = 4,167 shares (total cost ~$27,377); total sale proceeds ≈ $85,423.
The filing shows corresponding derivative entries (exercise/conversion) with $0 to reflect the extinguishment of the options as part of the exercise-and-sale.

Key Details

Transaction dates & prices:
- 2026-06-26: exercised 2,084 @ $6.57; sold 2,084 @ $20.00.
- 2026-06-29: exercised 2,083 @ $6.57; sold 2,083 @ $21.00.
Total: 4,167 shares exercised; ~$27,377 paid to exercise; ~$85,423 proceeds from sales.
Sales were executed pursuant to a 10b5-1 trading plan adopted March 13, 2026 (footnote F2).
This is an amended Form 4/A filed 2026-07-08 to restate the original 6/30/2026 Form 4 and to report the omitted exercise transactions; the original filing had timely reported the sales (footnote F1). Box 5 (beneficial ownership) was adjusted to correct an understatement.
Vesting note: the underlying option vests 25% after the first anniversary from 9/9/2024, then monthly (1/48th) thereafter; fully vested after four years (footnote F3).

Context

These were same-day exercise-and-sale (cashless-style) transactions: the options were exercised and the resulting shares were promptly sold, so this is generally a liquidity/compensation event rather than a straightforward buy signal.
The use of a 10b5-1 plan indicates the sales were pre-arranged and not necessarily reflective of a new view on company prospects.
The amendment corrects reporting of the exercises; investors should note the correction but not infer additional undisclosed trading.

Form 4/AAmended

Period: 2026-06-26

Chief Accounting Officer

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-06-26$6.57/sh+2,084$13,692→ 17,525 total
Sale
Common Stock
[F2][F1]
2026-06-26$20.00/sh−2,084$41,680→ 15,441 total
Exercise/Conversion
Common Stock
[F1]
2026-06-29$6.57/sh+2,083$13,685→ 17,524 total
Sale
Common Stock
[F2][F1]
2026-06-29$21.00/sh−2,083$43,743→ 15,441 total
Exercise/Conversion
Stock Option (Right to Buy)
[F1][F3]
2026-06-26−2,084→ 37,500 total
Exercise: $6.57Exp: 2034-10-23→ Common Stock (2,084 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
[F1][F3]
2026-06-29−2,083→ 35,417 total
Exercise: $6.57Exp: 2034-10-23→ Common Stock (2,083 underlying)

Footnotes (3)

[F1]This Form 4/A restates in its entirety the original Form 4 filed on 6/30/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.
[F2]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
[F3]25% of the shares subject to the option vested on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Signature

/s/ Nathan Salha, as Attorney-in-Fact for Craig Gracey|2026-07-08

1 file